Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug–drug interaction study of oral PCO371 in healthy adult Japanese males
jRCT2080224885Phase 1Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of PCO-371 in hypoparathyroidism, sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoints: Safety and tolerability of PCO371 with concomitant drugs, Pharmacokinetics of PCO371 with concomitant drugs and 1 more. Started Sep 2019; status: completed.
02
Drugs
PCO-371
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on jRCT2080224885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224885.